ResMed Announces Expansion Of Research Development And Innovation Facility

Minister of State, Department of Jobs, Enterprise and Innovation, John Perry TD, today announced that ResMed Inc., a global leader in the development, manufacturing and marketing of medical products to combat sleep and respiratory disorders, is expanding its Research Development and Innovation (RD&I) facility in Dublin over the next three years, with the creation of up to 50 new RD&I positions.

The investment is supported by the Irish Government through IDA Ireland. The new investment will allow ResMed to expand its RD&I facility at its existing operation in NexusUCD, the Innovation Partnerships Centre at University College Dublin.

The new jobs created will facilitate the development of a unique technology platform based on non-contact sensors designed to manage patients with chronic diseases in their home and will be carried through all stages; product standardisation, development of software algorithms, clinical trials and engineering for commercialisation. It will therefore rank among the most comprehensive medical device development projects ever undertaken by a multinational company in Ireland.

ResMed founder, Chairman and Chief Executive Officer Dr Peter Farrell said: "We believe there are great opportunities in growing our presence in Ireland. One of the factors that played a part in our 2011 acquisition of BiancaMed, a UCD spin-out company, was the tremendous advantage of being based in a country that strongly supports research and development."

Dr Conor Hanley, Managing Director of ResMed Ireland, said: "This investment will allow us to expand our world class team in Ireland and to continue to drive innovation and develop our technology for better monitoring and care of patients with sleep-disordered breathing and other respiratory disorders."

(CD)